Is it time to buy these 2 beaten-up ASX shares in April 2022?

These two ASX shares have dropped heavily, so, are they opportunities?

| More on:
A older man and younger man rest, exhausted but happy after a good boxing session.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • These two ASX shares have both fallen heavily since the start of the year
  • Doctor Care Anywhere is a digital health business that is expecting rapid revenue growth
  • Pushpay is a donation and church management business that is expecting further market share gains

Some ASX growth shares have been sold off significantly since the start of 2022.

With the ongoing growth that some of these businesses are generating, could there be some hidden innovations within these names?

Here are two contenders to consider.

Doctor Care Anywhere Group PLC (ASX: DOC)

Since the start of 2022, the Doctor Care Anywhere share price has fallen 56%. It is down around 75% since the middle of April 2021.

Doctor Care Anywhere describes itself as a United Kingdom-based telehealth company that is committed to delivering the best possible patient experience and clinical care through digitally-enabled, evidence-based pathways on its platform. It uses relationships with health insurers, healthcare providers and corporate customers to connect with patients to deliver telehealth services.

The company recently announced its result for the 12 months to 31 December 2021. It said that it beat FY21 revenue guidance. Total revenue grew by 114.7% to £25 million. There was a 105% increase in consultations to a total of 440,000.

In FY22, the ASX share expects revenue to be between £35 million to £38 million. This represents growth of between 40% to 50%.

By the end of the first half of FY23, the company aims to achieve an annualised run-rate profitability of earnings before interest, tax, depreciation and amortisation (EBITDA). It aims for an annualised run rate of revenue of between £45 million to £55 million.

Supporting the above expectations are three key development areas.

The first is continued organic revenue and consultation growth.

The second development is renegotiating key customer contracts, enhancing revenue and margins.

The final development is the launch of the company’s new operating model, enhancing productivity and margins.

Pushpay Holdings Ltd (ASX: PPH)

The Pushpay share price has fallen almost 20% since the start of the year.

This ASX share provides church management and donation tools for churches in the United States.

It processes billions of dollars of donations every year. In the first six months of Pushpay’s 2022 interim result, it announced that it had achieved a total processing volume of US$3.5 billion (which was 9% higher year on year).

The company says that it expects to see continued revenue growth as it executes its growth strategy and gains further market share in the US faith sector.

Despite the impacts of COVID-19 and subsequent reopening, Pushpay has not seen any material change in digital giving, reverting to non-digital means. This indicates to management that its customers in the US faith sector may have undergone “a fundamental technological shift as a result of the current environment.”

The ASX share is expecting further growth in the future. The company says it will enact strategies that will “allow the company to realise its considerable potential over the long term, while maintaining prudent financial discipline.” That involves expanding its existing suite of solutions, providing bundled product offerings to existing customers, growing its products utilised by customers, attracting new customers and expanding into new segments.

Pushpay recently gave an update that its total processing volume for the 11 months to February 2022 was up 10% year on year. It’s using its “strong” operating cash flow to pay down its debt.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Doctor Care Anywhere Group PLC and PUSHPAY FPO NZX. The Motley Fool Australia owns and has recommended PUSHPAY FPO NZX. The Motley Fool Australia has recommended Doctor Care Anywhere Group PLC. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

happy investor, share price rise, increase, up
Growth Shares

Here’s why brokers rate these ASX growth shares as buys

Here's why these growth shares could be buys next week...

Read more »

Woman smashes dollar sign for dividend share investment
Growth Shares

2 beaten down ASX shares named as buys by experts

Here are two beaten down shares that could be buys...

Read more »

smiling man holding phone technology
Growth Shares

Analysts name 2 excellent ASX shares to buy and hold

These ASX shares could be top buy and hold options...

Read more »

The hands of three people are cupped around soil holding three small seedling plants that are grouped together in the centre of the shot with the arms of the people extending into the edges of the picture representing ASX growth shares and it being a good time to buy for future gains
Opinions

Why I think these 2 ASX shares are ideal for growth investors

This current volatile period could be a great time to go hunting for compelling businesses with strong growth potential.

Read more »

happy investor, share price rise, increase, up
Growth Shares

Here’s where I’d invest $3,000 into ASX growth shares today

Some ASX growth shares are looking really good value, in my opinion.

Read more »

An ASX shares broker analysing a chart tracking the A2 Milk share price
Growth Shares

Analysts name 2 top ASX 200 shares to buy today

Here are a couple of top ASX 200 shares that experts rate highly...

Read more »

chart showing an increasing share price
Growth Shares

Experts have named these top growth shares as buys

These growth shares are highly rated...

Read more »

A hand holding a graph trending up, indicating a surging share price on the ASX
Growth Shares

Goldman Sachs names 2 mid cap ASX shares to buy

Here are two mid cap shares that could be buys...

Read more »